Ming‐Feng Hou

21.7k total citations
410 papers, 10.4k citations indexed

About

Ming‐Feng Hou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ming‐Feng Hou has authored 410 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Molecular Biology, 147 papers in Oncology and 96 papers in Cancer Research. Recurrent topics in Ming‐Feng Hou's work include Breast Cancer Treatment Studies (36 papers), Epigenetics and DNA Methylation (25 papers) and Cancer Cells and Metastasis (23 papers). Ming‐Feng Hou is often cited by papers focused on Breast Cancer Treatment Studies (36 papers), Epigenetics and DNA Methylation (25 papers) and Cancer Cells and Metastasis (23 papers). Ming‐Feng Hou collaborates with scholars based in Taiwan, China and United States. Ming‐Feng Hou's co-authors include Shyng‐Shiou F. Yuan, Hsueh‐Wei Chang, Pei‐Yi Chu, Jen‐Yang Tang, Wen‐Chun Hung, Chia‐Jung Li, Fu Ou‐Yang, Eing‐Mei Tsai, Meng‐Yu Wu and Jaw‐Yuan Wang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ming‐Feng Hou

395 papers receiving 10.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ming‐Feng Hou 4.5k 2.7k 2.4k 1.0k 1.0k 410 10.4k
Wei Chen 3.6k 0.8× 2.4k 0.9× 1.6k 0.6× 1.1k 1.0× 1.3k 1.3× 272 8.2k
Wen Zhang 4.3k 0.9× 2.1k 0.8× 1.8k 0.7× 1.5k 1.4× 1.2k 1.1× 494 11.0k
Jing Shen 4.5k 1.0× 1.7k 0.6× 1.8k 0.8× 1.2k 1.2× 832 0.8× 277 8.2k
Li Li 4.7k 1.0× 2.1k 0.8× 1.4k 0.6× 1.2k 1.2× 1.5k 1.5× 420 9.9k
Akira Hara 6.7k 1.5× 2.1k 0.8× 1.6k 0.6× 1.2k 1.1× 1.1k 1.1× 786 16.0k
King‐Jen Chang 4.1k 0.9× 3.7k 1.4× 2.4k 1.0× 912 0.9× 1.7k 1.7× 336 11.2k
Rong Li 4.5k 1.0× 2.2k 0.8× 1.5k 0.6× 758 0.7× 1.2k 1.2× 454 8.8k
Shuang Chen 6.5k 1.4× 1.6k 0.6× 1.9k 0.8× 1.8k 1.7× 842 0.8× 428 11.1k
Shu Zhang 4.6k 1.0× 1.9k 0.7× 1.8k 0.8× 1.3k 1.2× 723 0.7× 351 9.6k
Zhaoqian Liu 4.3k 1.0× 1.9k 0.7× 1.7k 0.7× 631 0.6× 959 0.9× 405 9.6k

Countries citing papers authored by Ming‐Feng Hou

Since Specialization
Citations

This map shows the geographic impact of Ming‐Feng Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Feng Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Feng Hou more than expected).

Fields of papers citing papers by Ming‐Feng Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Feng Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Feng Hou. The network helps show where Ming‐Feng Hou may publish in the future.

Co-authorship network of co-authors of Ming‐Feng Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Feng Hou. A scholar is included among the top collaborators of Ming‐Feng Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Feng Hou. Ming‐Feng Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Chi‐Wen, Shu‐Jyuan Chang, Wangta Liu, et al.. (2024). Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer. Cancer Genomics & Proteomics. 21(5). 523–532. 3 indexed citations
2.
Huang, Wei-Lun, Yin-Chou Hsu, Chi‐Wen Luo, et al.. (2024). Targeting the CDK7-MDK axis to suppresses irinotecan resistance in colorectal cancer. Life Sciences. 353. 122914–122914. 3 indexed citations
3.
Xie, Wenchong, et al.. (2024). Isolated point clutter suppression method for airborne STAP radar in wind farm environment. Signal Processing. 227. 109723–109723. 2 indexed citations
4.
Chuang, Ya-Ting, Jen‐Yang Tang, Jun‐Ping Shiau, et al.. (2023). Modulating Effects of Cancer-Derived Exosomal miRNAs and Exosomal Processing by Natural Products. Cancers. 15(1). 318–318. 8 indexed citations
5.
Shiau, Jun‐Ping, Jen‐Yang Tang, Ammad Ahmad Farooqi, et al.. (2023). Physapruin A Exerts Endoplasmic Reticulum Stress to Trigger Breast Cancer Cell Apoptosis via Oxidative Stress. International Journal of Molecular Sciences. 24(10). 8853–8853. 9 indexed citations
6.
Tang, Jen‐Yang, Ya-Ting Chuang, Jun‐Ping Shiau, et al.. (2022). Long Noncoding RNAs and Circular RNAs Regulate AKT and Its Effectors to Control Cell Functions of Cancer Cells. Cells. 11(19). 2940–2940. 11 indexed citations
7.
Shiau, Jun‐Ping, Jen‐Yang Tang, Fang‐Rong Chang, et al.. (2022). The Impact of Oxidative Stress and AKT Pathway on Cancer Cell Functions and Its Application to Natural Products. Antioxidants. 11(9). 1845–1845. 45 indexed citations
8.
Moi, Sin‐Hua, Ming‐Feng Hou, Fang‐Ming Chen, et al.. (2022). Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer. International Journal of Molecular Sciences. 23(18). 10539–10539. 1 indexed citations
9.
Shiau, Jun‐Ping, Shu‐Jyuan Chang, Mei‐Ren Pan, et al.. (2021). FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer. Biomedicines. 9(12). 1789–1789. 35 indexed citations
10.
Moi, Sin‐Hua, et al.. (2021). RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. Journal of Personalized Medicine. 11(7). 655–655. 3 indexed citations
11.
Wang, Yen‐Yun, Steven Lo, Yuk-Kwan Chen, et al.. (2020). Visfatin Enhances Breast Cancer Progression through CXCL1 Induction in Tumor-Associated Macrophages. Cancers. 12(12). 3526–3526. 35 indexed citations
12.
Kan, Jung‐Yu, Sin‐Hua Moi, Wen‐Chun Hung, et al.. (2020). Comprehensive Transcriptomic Analysis Identifies ST8SIA1 as a Survival-Related Sialyltransferase Gene in Breast Cancer. Genes. 11(12). 1436–1436. 14 indexed citations
13.
Wang, Yen‐Yun, Steven Lo, Ling‐Ming Tseng, et al.. (2019). Visfatin Mediates Malignant Behaviors through Adipose-Derived Stem Cells Intermediary in Breast Cancer. Cancers. 12(1). 29–29. 31 indexed citations
14.
Yang, Yi‐Fang, Yi‐Chen Lee, Yen‐Yun Wang, et al.. (2019). YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells. The Kaohsiung Journal of Medical Sciences. 35(7). 408–416. 34 indexed citations
15.
Yang, Cheng‐Hong, Sin‐Hua Moi, Li‐Yeh Chuang, et al.. (2017). Interaction of MRE11 and Clinicopathologic Characteristics in Recurrence of Breast Cancer: Individual and Cumulated Receiver Operating Characteristic Analyses. BioMed Research International. 2017. 1–9. 4 indexed citations
16.
Hung, Amos C., Steven Lo, Ming‐Feng Hou, et al.. (2016). Extracellular Visfatin-Promoted Malignant Behavior in Breast Cancer Is Mediated Through c-Abl and STAT3 Activation. Clinical Cancer Research. 22(17). 4478–4490. 52 indexed citations
17.
Ma, Hui, Chao Wang, Linlin Zhang, et al.. (2016). Transcription factor activity of estrogen receptor α activation upon nonylphenol or bisphenol A treatment enhances the in vitro proliferation, invasion, and migration of neuroblastoma cells. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Tang, Jen‐Yang, Jin‐Ching Lee, Ming‐Feng Hou, et al.. (2013). Alternative Splicing for Diseases, Cancers, Drugs, and Databases. The Scientific World JOURNAL. 2013(1). 703568–703568. 35 indexed citations
19.
Chuang, Kai‐Hsiang, Hsin-Ell Wang, Steve R. Roffler, et al.. (2011). In Vivo Positron Emission Tomography Imaging of Protease Activity by Generation of a Hydrophobic Product from a Noninhibitory Protease Substrate. Clinical Cancer Research. 18(1). 238–247. 26 indexed citations
20.
Lee, Yi-Chen, Yi‐Hsin Yang, Jinu‐Huang Su, et al.. (2011). High Visfatin Expression in Breast Cancer Tissue Is Associated with Poor Survival. Cancer Epidemiology Biomarkers & Prevention. 20(9). 1892–1901. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Chen Breakdown of academic impact, for papers by Wen Zhang Breakdown of academic impact, for papers by Jing Shen Breakdown of academic impact, for papers by Li Li Breakdown of academic impact, for papers by Akira Hara Breakdown of academic impact, for papers by King‐Jen Chang Breakdown of academic impact, for papers by Rong Li Breakdown of academic impact, for papers by Shuang Chen Breakdown of academic impact, for papers by Shu Zhang Breakdown of academic impact, for papers by Zhaoqian Liu
Rankless by CCL
2026